Inhibitor of streptokinase gene expression improves survival after group A streptococcus infection in mice
- 13 February 2012
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 109 (9), 3469-3474
- https://doi.org/10.1073/pnas.1201031109
Abstract
The widespread occurrence of antibiotic resistance among human pathogens is a major public health problem. Conventional antibiotics typically target bacterial killing or growth inhibition, resulting in strong selection for the development of antibiotic resistance. Alternative therapeutic approaches targeting microbial pathogenicity without inhibiting growth might minimize selection for resistant organisms. Compounds inhibiting gene expression of streptokinase (SK), a critical group A streptococcal (GAS) virulence factor, were identified through a high-throughput, growth-based screen on a library of 55,000 small molecules. The lead compound [Center for Chemical Genomics 2979 (CCG-2979)] and an analog (CCG-102487) were confirmed to also inhibit the production of active SK protein. Microarray analysis of GAS grown in the presence of CCG-102487 showed down-regulation of a number of important virulence factors in addition to SK, suggesting disruption of a general virulence gene regulatory network. CCG-2979 and CCG-102487 both enhanced granulocyte phagocytosis and killing of GAS in an in vitro assay, and CCG-2979 also protected mice from GAS-induced mortality in vivo. These data suggest that the class of compounds represented by CCG-2979 may be of therapeutic value for the treatment of GAS and potentially other Gram-positive infections in humans.This publication has 59 references indexed in Scilit:
- A Genome-Wide Analysis of Small Regulatory RNAs in the Human Pathogen Group A StreptococcusPLOS ONE, 2009
- Streptolysin S Inhibits Neutrophil Recruitment during the Early Stages ofStreptococcus pyogenesInfectionInfection and Immunity, 2009
- Genomic Evidence for the Evolution of Streptococcus equi: Host Restriction, Increased Virulence, and Genetic Exchange with Human PathogensPLoS Pathogens, 2009
- Genome Sequence of a Lancefield Group C Streptococcus zooepidemicus Strain Causing Epidemic Nephritis: New Information about an Old DiseasePLOS ONE, 2008
- Nucleotide Biosynthesis Is Critical for Growth of Bacteria in Human BloodPLoS Pathogens, 2008
- A direct link between carbohydrate utilization and virulence in the major human pathogen group A StreptococcusProceedings of the National Academy of Sciences of the United States of America, 2008
- Regulation of Polysaccharide Utilization Contributes to the Persistence of Group A Streptococcus in the OropharynxInfection and Immunity, 2007
- Identification and structural basis of binding to host lung glycogen by streptococcal virulence factorsNature Structural & Molecular Biology, 2006
- Maltodextrin Utilization Plays a Key Role in the Ability of Group A Streptococcus To Colonize the OropharynxInfection and Immunity, 2006
- Genome-Wide Analysis of Group A Streptococci Reveals a Mutation That Modulates Global Phenotype and Disease SpecificityPLoS Pathogens, 2006